Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

6 treatments under study, led by Exploratory Interviews

Research Leaders

5 sponsors active, led by Société Francophone Nutrition Clinique et Métabolisme

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Phase 1/2 (1)

Trial Status

Completed1
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT03408132Phase 1/2CompletedPrimary

Metabolic Balance Study of FE203799 in Patients With SBS With Intestinal Insufficiency

NCT04150302UnknownPrimary

Development and Validation of a Questionnaire to Measure the Impact of SBS and Its Treatments on Patients' Lives

Showing all 2 trials

Research Network

Common Treatments

  • Exploratory Interviews1
  • Delphi Process1
  • Semidirective Interviews1
  • Think Aloud Interviews1
  • Fe2037991

Active Sponsors

  • Société Francophone Nutrition Clinique et Métabolisme1
  • Beaujon Hospital1
  • GlyPharma Therapeutics1
  • Central Hospital, Nancy, France1
  • VectivBio AG1

Top Investigators

Activity Timeline